Related Experiment Video
Updated: Jul 6, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients
Sid Ahmed Merzouk1, Meriem Saker, Karima Briksi Reguig
1Département de Physique, Faculté des Sciences, Université de Tlemcen, Tlemcen, Algeria.
Lipids
|April 9, 2008
Summary
Omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), improve T cell function and oxidative status in type 1 diabetes. These fatty acids modulate cytokine secretion and enhance antioxidant defenses in diabetic lymphocytes.
Area of Science:
- Immunology
- Nutritional Science
- Metabolic Disorders
Background:
- Type 1 diabetes is associated with impaired T cell function and altered oxidative status.
- Lymphocyte dysfunction in diabetes may contribute to disease complications.
- n-3 polyunsaturated fatty acids (PUFAs) have known immunomodulatory and antioxidant properties.
Purpose of the Study:
- To investigate the in vitro effects of EPA and DHA on T cell function and oxidative status in type 1 diabetic patients.
- To assess the impact of these omega-3 fatty acids on lymphocyte proliferation, cytokine secretion, and intracellular antioxidant levels.
Main Methods:
- Human T lymphocytes from type 1 diabetic patients and healthy controls were cultured with EPA and DHA (15 microM).
- Assessed were T cell blastogenesis, interleukin-2 (IL-2) and -4 (IL-4) secretion, fatty acid composition, and intracellular oxidative status (reduced glutathione, catalase, SOD).
- Compared lymphocyte function and oxidative markers between diabetic and control groups, with and without n-3 PUFA treatment.
Main Results:
- Diabetic lymphocytes showed reduced proliferation, IL-2 production, and antioxidant activity compared to controls.
- EPA and DHA decreased T-lymphocyte proliferation and IL-2 but increased IL-4 secretion in both groups.
- n-3 PUFAs increased reduced glutathione, hydroperoxide levels, and catalase/SOD activity in diabetic T cells, with notable incorporation into phospholipids.
Conclusions:
- EPA and DHA demonstrate beneficial effects on T cell function in type 1 diabetes.
- These effects are linked to suppressed T cell proliferation, modulated cytokine secretion (IL-2, IL-4), and improved intracellular oxidative status.
- n-3 PUFA supplementation may represent a therapeutic strategy to enhance immune function in type 1 diabetes.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.